Table III.
Clinical characeristics of patients following RTX infusion.
| Patient no. | RTX dose | Prednisone dose (mg/kg/day) | Dependent-steroid dose (mg/m2/day) | Urine protein | Relapse rate/year | Follow-up (months) | Drugs used now (mg/kg/day) |
|---|---|---|---|---|---|---|---|
| 1 | 1 | 0 | – | – | 0 | 50 | No |
| 2 | 1 | 0.08 | 3.95 | – | 2 | 50 | Pred 0.08 |
| 3 | 1 | 0.1 | 1.88 | – | 2 | 47 | Pred 0.1 |
| 4 | 1 | 0.09 | 3.05 | – | 2 | 45 | Pred 0.17 |
| 5 | 1 | 0 | – | – | 1 | 41 | No |
| 6 | 1 | 0 | – | – | 0 | 40 | No |
| 7 | 1 | 0 | 13.5 | – | 1 | 37 | Pred 0.5, MMF |
| 8 | 1 | 0 | – | – | 0 | 34 | No |
| 9 | 1 | 0.05 | 2.02 | – | 2 | 34 | Pred 0.02 |
| 10 | 1 | 0 | – | – | 1 | 31 | No |
| 11 | 1 | 0 | – | – | 0 | 30 | No |
| 12 | 1 | 0 | – | – | 0 | 25 | No |
| 13 | 1 | 0 | – | – | 0 | 24 | No |
| 14 | 1 | 0 | – | – | 0 | 22 | No |
| 15 | 1 | 0.29 | 4.46 | – | 1 | 10 | Pred 0.4 |
| 16 | 1 | 0.13 | 1.41 | – | 1 | 7 | Pred 1.04 |
| 17 | 1 | 0 | – | – | 0 | 4 | No |
| 18 | 1 | 0.20 | – | – | 0 | 1 | Pred 0.2 |
| 19 | 1 | 0.20 | – | – | 0 | 1 | Pred 0.2 |
RTX, rituximab; Pred, prednisone; MMF, mycophenolate mofetil.